David A Smelson PSYD
Title Professor
Institution University of Massachusetts Medical School
Department Psychiatry
Address University of Massachusetts Medical School
365 Plantation Street, Biotech One
Worcester MA 01605
Telephone 508-856-3768
Email
Narrative

Curriculum Vitae

UNDERGRADUATE EDUCATION:
1
986-1988  BPS    College for Human Services, New York, New York.

GRADUATE EDUCATION:
1988-1989  MS       Upsala College, East Orange, New Jersey
1991-1995  Psy.D.   Illinois School of Professional Psychology, Chicago, Illinois.

 

 David Smelson

David Smelson, Psy.D. is Professor of Psychiatry and  Vice Chair of Clinical Research in the Department of Psychiatry of   the University of Massachusetts Medical School. Dr. Smelson is also the Director of Translational research of the Edith Nourse Rogers Memorial Veterans Hospital. He is the Director of Dual Diagnosis for the Veterans Affairs New England Health Care System (Network 1) and a member of the VA Mental Health QUERI. He is the Chair of the VA Mental Health QUERI Dual Diagnosis Workgroup and a Co-Chair of VA/DOD Dual Diagnosis Clinical Practice Guidelines

Curriculum Vitae

Research Interests:

  1. Addiction
  2. Persistent mental illness
  3. Co-occurring disorders of substance abuse and mental illness

Ongoing Projects:

  1. Health and Human Services-Center for Substance Abuse Treatment # TI16576, Award Amount $1,968,071. Title: Maintaining Independence and Sobriety through Systems Integration, Outreach and networking:  The MISSION Program. PI David Smelson,  Co-PI Anna Kline, Co-I Douglas Ziedonis, Bradley Sussner, Miklos Losonczy. October 2004-September 2009
  2. VA HSR&D Merit Review Grant # IIR-020-145, Award Amount $686,909. Title: A Brief Community Linkage Intervention for Dually Diagnosed individuals. PI David Smelson, Co-I’s Miklos Losonczy, Anna Kline, Bradley Sussner, Douglas Ziedonis, Fred Blow. February 2005-February 2009
  3. National Institute for Health Grant # R21 AT001350 Award Amount $586,063. Title:  Qigong Therapy for Treating Cocaine Addiction. PI David Smelson, Co-I Kevin Chen, Douglas Ziedonis, Anna Kline. June 2005-May 2009.
  4. National Institute of Health R03 DA020434-01 $155,500.  Cue-elicited Craving and Genetics in Cocaine Dependence. PI David Smelson, CO-I’s Paul Manowitz, Jay Tishfield, Anna Kline, Paul Lehrer, Bradley Sussner, Doug Ziedonis. September 2005-October 2008.
  5. Health and Human Services-Center for Mental Health Services $199,836. Title: The MISSION Fidelity Project. PI David Smelson. Co-PI Anna Kline, CO-I’s Bradley Sussner, Douglas Ziedonis, Miklos Losonczy. September 2006-September 2008.

 

Publications
1. Rogers E, Fernandez S, Gillespie C, Smelson D, Hagedorn HJ, Elbel B, Kalman D, Axtmayer A, Kurowski K, Sherman SE. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial. Addict Sci Clin Pract. 2013; 8:7.
  View in: PubMed
 
2. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic Association of GABA-A Receptor Alpha-2 and Mu Opioid Receptor with Cocaine Cue-Reactivity: Evidence for Inhibitory Synaptic Neurotransmission Involvement in Cocaine Dependence. Am J Addict. 2012 Sep; 21(5):411-5.
  View in: PubMed
 
3. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101.
  View in: PubMed
 
4. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
  View in: PubMed
 
5. Ellison ML, Mueller L, Smelson D, Corrigan PW, Torres Stone RA, Bokhour BG, Najavits LM, Vessella JM, Drebing C. Supporting the Education Goals of Post-9/11 Veterans with Self-Reported PTSD Symptoms: A Needs Assessment. Psychiatr Rehabil J. 2012; 35(3):209-17.
  View in: PubMed
 
6. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A Brief Treatment Engagement Intervention for Individuals with Co-occurring Mental Illness and Substance Use Disorders: Results of a Randomized Clinical Trial. Community Ment Health J. 2012 Apr; 48(2):127-32.
  View in: PubMed
 
7. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6.
  View in: PubMed
 
8. Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010 Feb; 30(1):12-24.
  View in: PubMed
 
9. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul; 37(4):727-36.
  View in: PubMed
 
10. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Womens Health Issues. 2009 Nov-Dec; 19(6):446-56.
  View in: PubMed
 
11. Fortuna JL, Smelson DA. The phenomenon of drug craving. J Psychoactive Drugs. 2008 Sep; 40(3):255-61.
  View in: PubMed
 
12. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res. 2008 Jul; 35(3):290-303.
  View in: PubMed
 
13. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008; 22(11):903-16.
  View in: PubMed
 
14. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse. 2007; 33(6):807-21.
  View in: PubMed
 
15. Smelson DA, Tunis SL, Nyhuis AW, Faries DE, Kinon BJ, Ascher-Svanum H. Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use. J Clin Psychopharmacol. 2006 Dec; 26(6):666-7.
  View in: PubMed
 
16. Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12.
  View in: PubMed
 
17. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7.
  View in: PubMed
 
18. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005 Sep; 11(5):315-39.
  View in: PubMed
 
19. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
  View in: PubMed
 
20. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003 Nov 26; 290(20):2693-702.
  View in: PubMed
 
21. Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003 Oct; 326(4):223-30.
  View in: PubMed
 
22. Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J Subst Abuse Treat. 2003 Jan; 24(1):75-9.
  View in: PubMed
 
23. Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6.
  View in: PubMed
 
24. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
  View in: PubMed
 
25. Smelson DA, Davis CW, Di Pano R, Johnson V, Losonczy MF, Ziedonis D. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis. 2002 Mar; 190(3):200-2.
  View in: PubMed
 
26. Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31.
  View in: PubMed
 
27. Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse. 2001 May; 27(2):391-7.
  View in: PubMed
 
28. Smelson DA, Roy A, Santana S, Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse. 1999 May; 25(2):377-81.
  View in: PubMed
 
29. Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Stern RG, Losonczy MF. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry. 1999 Jan; 60(1):41-4.
  View in: PubMed
 
30. Smelson DA, McGee-Caulfield E, Bergstein P, Engelhart C. Initial validation of the Voris Cocaine Craving Scale: a preliminary report. J Clin Psychol. 1999 Jan; 55(1):135-9.
  View in: PubMed
 
31. Smelson DA, Roy M, Roy A, Santana S. Electroretinogram in withdrawn cocaine-dependent subjects. Relationship to cue-elicited craving. Br J Psychiatry. 1998 Jun; 172:537-9.
  View in: PubMed
 
32. Roy A, Roy M, Smelson DA. Risperidone, ERG and cocaine craving. Am J Addict. 1998; 7(1):90.
  View in: PubMed
 
33. Smelson DA, Roy A, Roy M. Risperidone diminishes cue-elicited craving in withdrawn cocaine-dependent patients. Can J Psychiatry. 1997 Nov; 42(9):984.
  View in: PubMed
 
34. Roy M, Roy A, Smelson D, Brown S, Weinberger L. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication. Biol Psychiatry. 1997 Oct 1; 42(7):631-3.
  View in: PubMed
 
35. Smelson DA, Kordon ME, Rudolph B. Evaluating the diagnostic interview: obstacles and future directions. J Clin Psychol. 1997 Aug; 53(5):497-505.
  View in: PubMed
 
36. Desai P, Roy M, Roy A, Brown S, Smelson D. Impaired color vision in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Aug; 54(8):696-9.
  View in: PubMed
 
37. Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. Can J Psychiatry. 1997 May; 42(4):431.
  View in: PubMed
 
38. Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Feb; 54(2):153-6.
  View in: PubMed
 
39. Roy M, Smelson D, Roy A. Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biol Psychiatry. 1997 Jan 15; 41(2):252-3.
  View in: PubMed
 
40. Roy A, Smelson D, Lindeken S. Screening for pathological gambling among substance misusers. Br J Psychiatry. 1996 Oct; 169(4):523.
  View in: PubMed
 
41. Smelson DA, Roy A, Roy M. The electroretinogram and neuropsychological functioning in cocaine addicts. Can J Psychiatry. 1996 Aug; 41(6):415.
  View in: PubMed
 
42. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry. 1996 Apr; 168(4):507-11.
  View in: PubMed
 
43. Smelson DA. Adolescent substance abuse prevention. N J Med. 1993 Nov; 90(11):845-8.
  View in: PubMed
 
For assistance with using Profiles, please refer to the online tutorials at http://inside.umassmed.edu/is/profiles.aspx or contact the UMMS Help Desk at UMWHelpDesk@umassmed.edu or 508-856-8643.
 
Keyword
Last Name
Institution
    
 
 
 
Co-Authors  
Boyer, Edward
Ellison, Marsha
Fletcher, Richard
Rodrigues, Stephanie
Ziedonis, Douglas
See all (7) people
Physical Neighbors  
Foley, Ann
Kennedy, David
DiGirolamo, Gregory
Patel, Jayendra
Hodge, Steven

UMMS Home

Intranet

This is an official Page/Publication of the University of Massachusetts Worcester Campus
Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572